1. Home
  2. SRPT

SRPT

Sarepta Therapeutics Inc. (DE)

Logo Sarepta Therapeutics Inc. (DE)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Founded: 1980 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 11.1B IPO Year: 1997
Target Price: $160.82 AVG Volume (30 days): 844.1K
Analyst Decision: Strong Buy Number of Analysts: 17
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.80 EPS Growth: N/A
52 Week Low/High: $55.25 - $159.89 Next Earning Date: 04-30-2024
Revenue: $1,243,336,000 Revenue Growth: 33.26%
Revenue Growth (this year): 52.9% Revenue Growth (next year): 56.34%

Share on Social Networks: